| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |